These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 850846)

  • 1. Experience with the EMIT method of determining anticonvulsant levels in serum.
    Leary PM; Berger GM; Weer L; Prinsloo H
    S Afr Med J; 1977 Jan; 51(5):137-9. PubMed ID: 850846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Serum phenobarbital levels in epileptics].
    Loiseau P; Brachet A; Henry P
    Encephale; 1975; 1(4):341-57. PubMed ID: 1220957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Plasma levels of phenobarbital in epileptic children. Effect of combination with other anticonvulsants].
    Benedetti P; Antonozzi I; Curatolo P; Porro G
    Arch Fr Pediatr; 1979; 36(7):686-90. PubMed ID: 533347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evaluation of monitoring the efficacy of phenobarbital as an anticonvulsant agents using the fluorescence-polarization immunoassay].
    Karamehić J; Tulumović T; Uzeirbegović M; Trnovcević J; Asćerić M; Hadzibegić N
    Med Arh; 1998; 52(2):65-6. PubMed ID: 9769637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of serum levels during prolonged combination therapy with phenytoin and phenobarbitone.
    Müller FO; Aucamp AK; Hundt HK; Steyn JM; Olivier LR; Wessels WH
    S Afr Med J; 1977 Aug; 52(9):356-8. PubMed ID: 897947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of phenobarbitone dose on plasma phenobarbitone levels in epileptic patients.
    Eadie MJ; Lander CM; Hooper WD; Tyrer JH
    Proc Aust Assoc Neurol; 1976; 13():89-96. PubMed ID: 1029012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug interactions during anticonvulsant therapy in childhood: diphenylhydantoin, primidone, phenobarbitone, clonazepam, nitrazepam, carbamazepin and dipropylacetate.
    Windorfer A; Sauer W
    Neuropadiatrie; 1977 Feb; 8(1):29-41. PubMed ID: 321985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Special viewpoints in the treatment with anticonvulsants in childhood. Value of determination of serum level of anticonvulsants in the treatment of seizures].
    Windorfer A
    Fortschr Med; 1974 Oct; 92(28):1102-4. PubMed ID: 4457423
    [No Abstract]   [Full Text] [Related]  

  • 9. Valproic acid and phenobarbital blood levels during the first month of treatment with the ketogenic diet.
    Coppola G; Verrotti A; D'Aniello A; Arcieri S; Operto FF; Della Corte R; Ammendola E; Pascotto A
    Acta Neurol Scand; 2010 Oct; 122(4):303-7. PubMed ID: 21077847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of total and free anticonvulsant serum levels in clinical practice.
    Beran RG; Lewis JH; Nolte JL; Westwood AP
    Clin Exp Neurol; 1985; 21():69-77. PubMed ID: 3939613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variability of plasma phenobarbitone concentration in Asian children in Singapore.
    Lee HS
    Ther Drug Monit; 1984; 6(2):182-8. PubMed ID: 6740737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The determination of anticonvulsant drug levels in blood by enzyme immunoassay: method and clinical application (author's transl)].
    Igari J; Kanazawa T; Takahashi K
    Rinsho Byori; 1980 Oct; 28(10):1013-9. PubMed ID: 7019508
    [No Abstract]   [Full Text] [Related]  

  • 13. [Investigations of serum levels of drugs in children receiving anticonvulsant medication. I. General evaluation of serum concentrations of diphenylhydantoin, primidone and phenobarbitone (author's transl)].
    Windorfer A; Gädeke R; Sauer M
    Z Kinderheilkd; 1975; 119(1):15-24. PubMed ID: 1124582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subtherapeutic levels of phenytoin with standard doses in infants: need to review dosage schedule.
    Rane CT; Gogtay NJ; Kadam VS; Powar HS; Dalvi SS; Kshirsagar NA
    Br J Clin Pharmacol; 1999 Sep; 48(3):465-6. PubMed ID: 10576792
    [No Abstract]   [Full Text] [Related]  

  • 15. The prevalence of adverse reactions to anticonvulsants in children with epilepsy.
    Leary PM; Luss K
    S Afr Med J; 1989 Jun; 75(11):535-7. PubMed ID: 2499067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of anticonvulsant therapy on serum 25-hydroxyvitamin D level.
    Sumi K; Sugita T; Shimotsuji T; Seino Y; Mimaki T; Yabuuchi H
    Tohoku J Exp Med; 1978 Jul; 125(3):265-9. PubMed ID: 694926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of serum levels of phenobarbitone in control of epilepsy.
    Shriyan IC; Bajaj RT
    Indian J Pediatr; 1988; 55(3):427-30. PubMed ID: 3225032
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical value of determination of serum concentration of antiepileptics.
    Wang L; Zuo QH; Liu SR; Wang SH
    Chin Med J (Engl); 1984 Mar; 97(3):165-70. PubMed ID: 6432478
    [No Abstract]   [Full Text] [Related]  

  • 19. [Determination of antiepileptic serum levels in patients with mono- and polytherapy in correlation with the clinical picture of the disease].
    Subakov M; Milovanović DD; Sinanović O
    Med Arh; 1985; 39(5):197-201. PubMed ID: 3917051
    [No Abstract]   [Full Text] [Related]  

  • 20. Monitoring of phenobarbitone in epileptic children.
    Singh LM; Mehta S; Vohra RM; Nain CK
    Int J Clin Pharmacol Ther Toxicol; 1987 Jan; 25(1):18-22. PubMed ID: 3104216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.